Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Goodwin Biotech Signs Mfg. Pact | Contract Pharma
Breaking News, Collaborations & Alliances

Goodwin Biotech Signs Mfg. Pact

Goodwin Biotechnology, Inc. has signed a development and manufacturing agreement with a multinational biopharmaceutical client, under which Goodwin will develop the process to manufacture a therapeutic monoclonal antibody conjugate for diagnostic imaging

Goodwin Biotechnology, Inc. has signed a development and manufacturing agreement with a multinational biopharmaceutical client, under which Goodwin will develop the process to manufacture a therapeutic monoclonal antibody conjugate for diagnostic imaging purposes. The product will be manufactured under cGMP conditions as a kit for radio-labeling for use in clinical trials. Terms of the agreement were not disclosed.

“This project will allow us to utilize our extensive experience and expertise in bio-conjugation technologies that we have honed over the last few years,” said Muctarr Sesay, Ph.D., vice president of process development at Goodwin Biotechnology. “We have had great history in developing and producing antibody-drug conjugates for diagnostic imaging and therapeutics, and this project is already underway with excellent progress.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters